Management of Xerostomia in Hypertension Patients with Smoking Habits
DOI:
https://doi.org/10.55927/ijis.v5i2.3Keywords:
Xerostomia, Hypertension, Smoking, SalivaAbstract
Xerostomia is a dry mouth complaint frequently found in patients with systemic diseases, particularly hypertension. In addition to the use of antihypertensive medications, smoking habits also contribute to decreased salivary secretion and salivary gland damage. Objective: To explore the relationship between hypertension and smoking habits in the occurrence of xerostomia, as well as to review relevant clinical implications and management strategies. Methods: Literature searches were conducted in PubMed/PMC, ScienceDirect, and publisher portals (TandF, JADA, MDPI) up to August 2025 using the keywords: xerostomia, hyposalivation, salivary flow, hypertension, antihypertensive, diuretic, beta-blocker, ACE inhibitor, ARB, smoking. Literature Review: Most studies indicate that the prevalence of xerostomia is higher in hypertensive patients who smoke compared to non-smokers. The main mechanisms underlying this condition are the xerogenic pharmacological effects of antihypertensive drugs and the toxic effects of nicotine on salivary gland function. Xerostomia in this group is associated with an increased risk of dental caries, periodontal disease, and impaired quality of life. Conclusion: The combination of hypertension and smoking habits has been proven to significantly increase the risk of xerostomia. Management of xerostomia in this group should be carried out comprehensively, including controlling systemic risk factors, selecting appropriate antihypertensive therapy, smoking cessation, and local interventions to maintain salivary function
References
Adolfsson A, Lenér F, Marklund B, Mossberg K, Çevik-Aras H. Prevalence of dry mouth in adult patients in primary health care. Acta Odontol Scand. 2022;80(8):605-610. doi:10.1080/00016357.2022.2069282
De Almeida PDV, Grégio AMT, Machado MAN, de Lima AAS, Azevedo LR. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract. 2008;9(3):72- 80.
Dyasanoor S, Saddu SC. Association of xerostomia and assessment of salivary flow using modified Schirmer test among smokers and healthy individuals: a preliminary study. J Clin Diagn Res. 2014;8(1):ZC11-ZC13. doi:10.7860/JCDR/2014/6650.3846
Ito K, Izumi N, Funayama S, et al. Characteristics of medication-induced xerostomia and effect of treatment. PLoS One. 2023;18(1 January):1-14. doi:10.1371/journal.pone.0280224
Kapourani A, Kontogiannopoulos KN, Manioudaki AE, et al. A Review on Xerostomia and Its Various Management Strategies: The Role of Advanced Polymeric Materials in the Treatment Approaches. Polymers (Basel).2022;14(5). doi:10.3390/polym14050850
Kurniawan AV, Amtha R, Gunardi I, Heriandi A, Sari EF. The Impact of Electronic and Conventional Cigarette Use on Saliva Profile and Oral Microbiota in Adolescents. Asian Pac J Cancer Prev. 2025;26(1):309-318. doi:10.31557/APJCP.2025.26.1.309
Langari SF, Hosseini SR, Bijani A, et al. Association between antihypertensive drugs and the elderly’s oral health- related quality of life: Results of the Amirkola cohort study. Casp J Intern Med. 2022;13(3):582-588. doi:10.22088/cjim.13.3.582
Mosannen Mozaffari P, Delavarian Z, Fekrazad R, et al. Evaluation of the Effect of Photobiomodulation on Radiation-Induced Xerostomia in Head and Neck Cancer Patients: A Randomized Clinical Trial. J lasers Med Sci. 2024;15:e4.doi:10.34172/jlms.2024.04
Nederfors T, Nauntofte B, Twetman S. Effects of furosemide and bendroflumethiazide on saliva flow rate and composition. Arch Oral Biol. 2004;49(7):507-513. doi:10.1016/j.archoralbio.2004.01.00 7
Ostrowska M, Settaf-Cherif L, Kiersztyn J, et al. Drug-induced Xerostomia and hyposalivation in patients with overactive bladder: a prospective open-label observational study comparing antimuscarinics and β3-adrenoceptor agonists. Sci Rep. 2025;15(1):85-94. doi:10.1038/s41598-025-09720-6
Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(1):28-46. doi:10.1016/j.tripleo.2003.07.010
Prasanthi B, Kannan N, Patil R. Effect of Diuretics on Salivary Flow, Composition and Oral Health Status: A Clinico-biochemical Study. Ann Med Health Sci Res. doi:10.18332/tid/157203
Ramírez L, Sánchez I, Muñoz M, et al. Risk factors associated with xerostomia and reduced salivary flow in hypertensive patients. Oral Dis. 2023;29(3):1299-1311. doi:10.1111/odi.14090
Sánchez Garrido I, Ramírez L, Muñoz Corcuera M, et al. Xerostomia and Salivary Dysfunction in Patients With Diabetes Mellitus. A Cross- Sectional Study. J Oral Pathol Med. 2024;53(10):622-636. doi:10.1111/jop.13583
Sangalli L, Eldomiaty W, Miller CS. Xerogenic medications may contribute to decreased unstimulated salivary flow in patients with oral burning and/or gastroesophageal reflux disease. Front Dent Med. 2023;4(February):1-8. doi:10.3389/fdmed.2023.1047235
Scientists B. Biomedical and Biotechnology. 2022;6(1):1-12. doi:10.4103/bbrj.bbrj
Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2015;11:45-51. doi:10.2147/TCRM.S76282
Zięba S, Zalewska A, Żukowski P, Maciejczyk M. Can smoking alter salivary homeostasis? A systematic review on the effects of traditional and electronic cigarettes on qualitative and quantitative saliva parameters. Dent Med Probl. 2024;61(1):129-144. doi:10.17219/dmp/172084
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ana Medawati, Sri Utami, intan Wahyu Aisyah
This work is licensed under a Creative Commons Attribution 4.0 International License.
